Skip to content

Fresh Versus Old Red Blood Cells for Transfusion

Immunomodulatory Properties of Fresh Versus Stored Packed Red Blood Cells for Transfusion

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01319552
Enrollment
14
Registered
2011-03-21
Start date
2008-12-31
Completion date
2010-10-31
Last updated
2015-06-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Iron, Abnormal Blood Level, Other Abnormal Blood Chemistry

Keywords

red blood cells, transfusion, storage, sickle cell disease, β-thalassemia, hemoglobin-associated iron

Brief summary

Packed red blood cell units destined for transfusion can be stored for up to 42 days prior to transfusion based on Food and Drug Administration (FDA) guidelines. Recent studies suggest that certain patients transfused with blood stored for longer duration have poorer outcomes than patients transfused fresher blood. The investigators' hypothesis is that the delivery of an immediate and substantial load of hemoglobin-associated iron from a stored unit of blood leads to changes that explain the differences in outcome between patients transfused old versus fresh blood. The investigators propose to test this hypothesis in humans by transfusing an individual's own blood, both fresh and after storage, and comparing levels of various outcome measures.

Detailed description

Participants in this study will be asked to participate in a standard blood donation. The blood will be processed per standards at the investigators regional blood center (New York Blood Center) and then split into two equal units and shipped to Columbia University Medical Center for storage and transfusion. One unit will be transfused back into the same individual fresh (i.e. between 3-7 days after donation). The other unit will be transfused 42 days after donation. Blood samples will be drawn before, during, and after transfusion to measure levels of various analytes.

Interventions

PROCEDUREFresh transfusion

1 unit autologous transfusion of red blood cells stored for 3-7 days under standard conditions

PROCEDUREOld transfusion

1 unit autologous transfusion of red blood cells stored for 40-42 days under standard conditions

Sponsors

National Heart, Lung, and Blood Institute (NHLBI)
CollaboratorNIH
Columbia University
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

* healthy * male body weight \>130 lbs, female body weight \> 155 lbs * male height \>5'1, female height \>5'5 * hemoglobin \>13.3 g/dL

Exclusion criteria

* ineligible for donation based on the New York Blood Center autologous blood donor questionnaire * systolic blood pressure \>180 or \<90 mm Hg * diastolic blood pressure \>100 or \<50 mm Hg * heart rate \<50 or \>100 * temperature \>99.5 F prior to donation * temperature \>100.4 F or subjective feeling of illness prior to transfusion * positive results on standard blood donor infectious disease testing * pregnancy.

Design outcomes

Primary

MeasureTime frameDescription
Measure of Non-transferrin-bound Ironfour hours after transfusionComparison of increase in non-transferrin-bound iron for each participant between his or her fresh and old blood transfusion four hours after transfusion.

Countries

United States

Participant flow

Recruitment details

The recruitment of volunteers began in December 2008 and ended in October 2010. All the volunteers were recruited at Columbia University.

Participants by arm

ArmCount
Transfusion
Fresh transfusion: 1 unit autologous transfusion of red blood cells stored for 40-42 days under standard conditions 1 unit autologous transfusion of red blood cells stored for 3-7 days under standard conditions Old transfusion: 1 unit autologous transfusion of red blood cells stored for 40-42 days under standard conditions
14
Total14

Baseline characteristics

CharacteristicTransfusion
Age, Categorical
<=18 years
0 Participants
Age, Categorical
>=65 years
0 Participants
Age, Categorical
Between 18 and 65 years
14 Participants
Ethnicity (NIH/OMB)
Hispanic or Latino
2 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
12 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
Race (NIH/OMB)
Asian
2 Participants
Race (NIH/OMB)
Black or African American
1 Participants
Race (NIH/OMB)
More than one race
0 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants
Race (NIH/OMB)
White
11 Participants
Region of Enrollment
United States
14 participants
Sex: Female, Male
Female
4 Participants
Sex: Female, Male
Male
10 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
— / —
other
Total, other adverse events
3 / 14
serious
Total, serious adverse events
0 / 14

Outcome results

Primary

Measure of Non-transferrin-bound Iron

Comparison of increase in non-transferrin-bound iron for each participant between his or her fresh and old blood transfusion four hours after transfusion.

Time frame: four hours after transfusion

ArmMeasureValue (MEAN)Dispersion
Fresh TransfusionMeasure of Non-transferrin-bound Iron0.16 μMStandard Deviation 0.99
Old TransfusionMeasure of Non-transferrin-bound Iron3.17 μMStandard Deviation 3.26

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026